Clinical Trial Update: Efficacy Phase IIa Study of CVXL-0107 in Advanced Parkinson's Disease [Phase 2]

View source ↗

Summary

Clinical trial update indicates the Phase IIa efficacy study of CVXL-0107 in advanced Parkinson's disease has completed. No efficacy results are provided in the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• CVXL-0107

Snippet

Sponsor: CleveXel Pharma | Conditions: Idiopathic Parkinson Disease | Phase 2 | Status: COMPLETED